BIOVECTRA
Edit

BIOVECTRA

http://www.biovectra.com/
Last activity: 09.03.2026
Active
Categories: ActiveChemicalCommerceDevelopmentDrugInformationManufacturingMedtechProductionSpace
Expertise in both microbial fermentation and chemical synthesis allows us to tackle today’s development pipeline’s increasingly complex molecules. In fact, we thrive on the vexing challenges few CDMOs would have either the expertise or desire to address. Bold vision, along with the passion and commitment to make that vision reality, is at the heart of our organization.

We are a forward-thinking, North American CDMO Pharmaceutical company specializing in clinical-to-commercial scale production capabilities for:

Synthetic small molecules
Fermented small molecules
Highly potent APIs
Biologics
Bioreagents
Likes
542
Followers
985
Followers
9.86K
Website visits
8.4K /mo.
Mentions
8
Location: Canada, Prince Edward Island, Charlottetown
Employees: 501-1000
Phone: +1 902-566-9116
Total raised: $37.5M
Founded date: 1970

Investors 4

Funding Rounds 1

DateSeriesAmountInvestors
--$37.5M-

Mentions in press and media 8

DateTitleDescription
09.03.2026Agilent покупает американского производителя инструментов и реагентов для исследований рака Biocare за $950 млнКомпания Agilent Technologies Inc. договорилась о приобретении частной компании Biocare Medical, которая производит оборудование и материалы для исследований рака. Сделка полностью оплачивается денежными средствами и оценивается в $950 млн....
29.04.2024Streamlining the mRNA Manufacturing Supply Chain: Challenges and Solutions Provided by CDMOs, Upcoming Webinar Hosted by Xtalkswww.biovectra.com In this free webinar, attendees will gain insights into the benefits of consolidating mRNA manufacturing processes with a single, integrated CDMO to streamline operations, reduce supply chain complexity and minimize the ri...
08.03.2022Considerations for Microbial Fermentation: Single Use vs. Stainless Steel Fermenters, Upcoming Webinar Hosted by XtalksRecent innovations… have led single-use fermenters to gain ground quickly — but knowing when to use stainless steel versus single-use fermenters, or even a hybrid approach, can be challenging. TORONTO (PRWEB) March 08, 2022 For decades, mic...
18.11.2021BioVectra gets $39.8 million in funding to manufacture mRNA vaccine here and in N.S.CHARLOTTETOWN, P.E.I. — A Prince Edward Island bio-tech company is leading the charge in domestic vaccine development in P.E.I. after receiving provincial and federal funding. BioVectra, a bio-tech company with facilities in P.E.I. and Nova...
21.10.2021adMare’s President & CEO Gordon C. McCauley is Appointed to BIOVECTRA Board of DirectorsCharlottetown, P.E.I. (October 21, 2021) – BIOVECTRA, a leading Canadian biotech and pharmaceutical CDMO has appointed Gordon C. McCauley, President and CEO of adMare BioInnovations and Steven Klosk CEO (retired) Cambrex Corporation, to its...
11.03.2021PhaseBio Pharmaceuticals and BioVectra Enter into Supply Agreement to Support Development and Commercialization of BentracimabMALVERN, Pa. & SAN DIEGO--(BUSINESS WIRE)--Mar 11, 2021-- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary ...
15.04.2018BioVectra gets $5 million from ACOA to expand operations in Nova Scotia, hire more staffWINDSOR, N.S. - More bioscience jobs are coming to Windsor, following an investment from the federal government into Charlottetown-based BioVectra. During a funding announcement at the BioVectra facility in the Windsor Industrial Park on Ap...
-Strategic Innovation Fund Invests $37.5M into BioVectra Inc.BioVectra Inc., based in Charlottetown, Prince Edward Island, serves the medical and biotech sectors and manufactures pharmaceutical products. These products have been used in the treatment of illnesses such as kidney disease, cancer, multi...

Reviews 0

Sign up to leave a review

Sign up Log In